ABA Life lands $40 million to build a Moroccan healthtech champion

Healthtech start-ups rarely turn a profit in their first five years. ABA Life says it has. That is the detail that makes its new $40 million investment from pan-African private equity firm Admaius Capital Partners worth a closer look.

The deal is subject to customary closing conditions and clearance from Morocco's Competition Council. ABA Life, founded in 2021, is the healthcare arm of ABA Technology, which was founded and is chaired by Mohamed Benouda. It combines artificial intelligence, medical technology, telemedicine, connected health infrastructure and clinical services. It also works with public institutions and foundations on programmes meant to widen access to care.

The funds will be used for...

The money is split across three priorities:

• Expanding the "AI for Sovereign Health" programme, including the Mediot AI platform and clinical intelligence tools
• Deploying the group's healthcare technologies and services at larger scale
• Entering international markets

Benouda says the aim is to make ABA Life a global healthtech reference and one of Morocco's next unicorns. Admaius' Selim Ettriqui pointed to the company's mix of medical devices, connected infrastructure, care operations and proprietary technology built in Morocco.

Why does it matter?

Profitability and public-sector partnerships are a strong combination. Many health AI ventures depend on pilots that never grow. ABA Life argues it has already moved past that stage, and an investor with a pan-African mandate appears to agree. Marlon Chigwende, Managing Partner at Admaius, cited a proven business model and strong technology foundations.

The word "sovereign" also matters. It signals that clinical AI can be developed and controlled locally rather than imported. That idea will be familiar to Gulf readers.

The context

Across the GCC, governments are building national health data platforms and AI strategies under programmes such as Saudi Vision 2030 and the UAE's digital health initiatives. Data governance and local capability sit at the centre of those plans. Morocco is chasing a similar goal from a different starting point.

So the questions for ABA Life are practical. Can a model built around Moroccan public partnerships travel? Will regulators in other markets accept its clinical AI? And can it keep its margins while expanding? Gulf health authorities and investors looking for partners in North and West Africa will be watching the answers.